Jupiter Financial Statements From 2010 to 2026

JUNS Stock  USD 0.60  0.02  3.23%   
Jupiter Neurosciences' financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Jupiter Neurosciences' valuation are provided below:
Gross Profit
-2.2 M
Market Capitalization
20.6 M
Earnings Share
(0.23)
There are over one hundred nineteen available fundamental trends for Jupiter Neurosciences, which can be analyzed over time and compared to other ratios. All traders should confirm Jupiter Neurosciences' regular fundamentals against the performance from 2010 to 2026 and make sure the trends continue to evolve in the right direction. Market Cap is likely to gain to about 291 M in 2026. Enterprise Value is likely to gain to about 287.7 M in 2026

Jupiter Neurosciences Total Revenue

0.0

Check Jupiter Neurosciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Jupiter Neurosciences' main balance sheet or income statement drivers, such as Interest Expense of 303 K, Selling General Administrative of 2.6 M or Other Operating Expenses of 3.7 M, as well as many indicators such as Price To Sales Ratio of 731, Dividend Yield of 0.0 or PTB Ratio of 69.76. Jupiter financial statements analysis is a perfect complement when working with Jupiter Neurosciences Valuation or Volatility modules.
  
Build AI portfolio with Jupiter Stock
Check out the analysis of Jupiter Neurosciences Correlation against competitors.

Jupiter Neurosciences Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets7.5 M7.1 M1.3 M
Slightly volatile
Short and Long Term Debt Total237.9 K250.4 KM
Slightly volatile
Other Current Liabilities1.3 M1.4 M3.5 M
Slightly volatile
Total Current Liabilities1.7 M1.8 M4.6 M
Slightly volatile
Accounts Payable237.5 K320.5 K178.4 K
Slightly volatile
Cash4.6 M4.3 M782.4 K
Slightly volatile
Cash And Short Term Investments4.6 M4.3 M782.4 K
Slightly volatile
Common Stock Shares Outstanding22.3 M33.1 M15 M
Slightly volatile
Liabilities And Stockholders Equity7.5 M7.1 M1.3 M
Slightly volatile
Other Current Assets1.1 MM196.4 K
Slightly volatile
Other Stockholder Equity36.5 M34.7 M10.3 M
Slightly volatile
Total Liabilities1.7 M1.8 M4.7 M
Slightly volatile
Total Current Assets5.6 M5.3 M986.2 K
Slightly volatile
Short Term Debt214.7 K226 KM
Slightly volatile
Common Stock1.9 K3.8 K1.2 K
Slightly volatile
Net Receivables101 K113.6 K124 K
Slightly volatile
Short and Long Term Debt160 K168.4 K344.9 K
Slightly volatile
Capital Stock2.2 K3.8 K1.3 K
Slightly volatile
Long Term Debt85.4 K96 K104.8 K
Slightly volatile

Jupiter Neurosciences Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Interest Expense303 K285.6 K299.7 K
Very volatile
Selling General Administrative2.6 MMM
Slightly volatile
Other Operating Expenses3.7 M3.6 M2.8 M
Slightly volatile
Research Development822 K443.4 K800.1 K
Pretty Stable
Total Operating Expenses3.7 M3.6 M2.8 M
Slightly volatile
Interest Income6.7 K6.4 K1.2 K
Slightly volatile
Gross Profit199.5 K210 K831.5 K
Slightly volatile
Income Tax Expense143.3 K161.3 K176 K
Slightly volatile

Jupiter Neurosciences Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation1.2 M2.1 M1.1 M
Slightly volatile
Begin Period Cash Flow31.1 K32.7 K62.4 K
Pretty Stable
Other Cashflows From Financing Activities11.9 M11.4 M3.2 M
Slightly volatile
Total Cash From Financing Activities9.2 M8.8 M1.8 M
Slightly volatile
End Period Cash Flow4.6 M4.3 M782.4 K
Slightly volatile
Change To Inventory36 K40.5 K44.2 K
Slightly volatile
Depreciation34.6 K39 K42.5 K
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio731696253
Slightly volatile
Days Sales Outstanding32.7336.8240.1889
Slightly volatile
Average Payables174.5 K210.7 K199.5 K
Slightly volatile
Stock Based Compensation To Revenue1.623.151.3427
Slightly volatile
EV To Sales739703255
Slightly volatile
Sales General And Administrative To Revenue11.0310.514.3803
Slightly volatile
Research And Ddevelopement To Revenue2.073.642.1256
Slightly volatile
Capex To Revenue0.00.00.0
Slightly volatile
Cash Per Share0.120.1310.0255
Slightly volatile
Income Quality1.511.440.3495
Slightly volatile
Current Ratio2.192.080.4011
Slightly volatile
Receivables Turnover7.148.038.7646
Slightly volatile
Average Receivables50.5 K56.8 K62 K
Slightly volatile
Revenue Per Share0.00780.00820.0895
Slightly volatile
Interest Debt Per Share0.01770.01860.1205
Slightly volatile
Debt To Assets0.03840.0404117
Slightly volatile
Operating Cycle32.7336.8240.1889
Slightly volatile
Ebt Per Ebit1.250.911.2703
Slightly volatile
Quick Ratio2.192.080.4011
Slightly volatile
Net Income Per E B T0.830.941.0241
Slightly volatile
Cash Ratio1.771.690.3211
Slightly volatile
Cash Conversion Cycle32.7336.8240.1889
Slightly volatile
Days Of Sales Outstanding32.7336.8240.1889
Slightly volatile
Fixed Asset Turnover2.461.652.6508
Slightly volatile
Debt Ratio0.03840.0404117
Slightly volatile
Price Sales Ratio731696253
Slightly volatile
Asset Turnover1.461.141.7087
Slightly volatile

Jupiter Neurosciences Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap291 M277.2 M106.9 M
Slightly volatile
Enterprise Value287.7 M274 M107.2 M
Slightly volatile

Jupiter Fundamental Market Drivers

Forward Price Earnings10.0503
Cash And Short Term Investments3.8 M

About Jupiter Neurosciences Financial Statements

Jupiter Neurosciences shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Jupiter Neurosciences investors may analyze each financial statement separately, they are all interrelated. The changes in Jupiter Neurosciences' assets and liabilities, for example, are also reflected in the revenues and expenses on on Jupiter Neurosciences' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Stock Based Compensation To Revenue 3.15  1.62 
Sales General And Administrative To Revenue 10.51  11.03 
Research And Ddevelopement To Revenue 3.64  2.07 
Revenue Per Share 0.01  0.01 
Ebit Per Revenue(16.92)(16.07)

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Jupiter Stock Analysis

When running Jupiter Neurosciences' price analysis, check to measure Jupiter Neurosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Jupiter Neurosciences is operating at the current time. Most of Jupiter Neurosciences' value examination focuses on studying past and present price action to predict the probability of Jupiter Neurosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Jupiter Neurosciences' price. Additionally, you may evaluate how the addition of Jupiter Neurosciences to your portfolios can decrease your overall portfolio volatility.